Before starting growth hormone therapy, the median BHI-SDS was lower in patients with isolated growth hormone deficiency and multiple pituitary hormone deficiencies, at −0.97 and −1.85, respectively [45]. This evidence concerns the gene GH1 and hypopituitarism.